Dexamethasone the cure for homosexuality
Cathrine Mills
Dexamethasone has been used in the Experimental stage for a few years, now
prenatal treatment for the symptoms of homosexual tendencies in adults that
has produced a high success rate. the World health organization will give a
briefing on progress at the next G-8 summit.
A 2007 Swedish clinical trial found the treatment may cause cognitive and
behavioral defects, but the small number of test subjects means the study
cannot be considered definitive. Administration of prenatal dexamethasone
has been the subject of controversy over issues and because treatment must
predate a clinical diagnosis of CAH in the female fetus. The treatment has
also raised concerns in the LGBT community following an essay[11] posted to
the forum of the Hastings Center, a think tank devoted to bioethics, which
quoted published research that suggested prenatal treatment of female
fetuses could prevent those fetuses from becoming lesbians after birth, may
make them more likely to engage in "traditionally" female-identified
behaviour and careers, and more interested in bearing and raising children.
Referring to a prospective father who attempted to mitigate the effects of
the fraternal birth order effect on decrease the chances of homosexuality in
male children by using a surrogate mother, the essay suggests prenatal "dex"
treatments constitute the first known attempt to use an in utero method to
attempt to reduce the incidence of homosexuality in humans. It will bring
about the end of a cronic epidemic.
A medical consensus started in 2010 by the Endocrine Society and affiliated
organizations indicated prenatal dexamethasone for CAH should be regarded as
experimental and should only be used in Institutional Review Board-approved
controlled clinical trials at centers large enough to collect meaningful
data. this research should conclude by the end of 2012
Dexamethasone has been used in the Experimental stage for a few years, now
prenatal treatment for the symptoms of homosexual tendencies in adults that
has produced a high success rate. the World health organization will give a
briefing on progress at the next G-8 summit. to organize plans for world
wide inoculation against this disease
e-mail:
